January 2026 FDA Recall Diclofenac Sodium by Sun Pharmaceutical Industries Inc
D-0342-2026 - Failed Viscosity Specifications

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on January 27, 2026 for the product Diclofenac Sodium. The FDA reported the reason for recall as failed viscosity specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0342-2026

Reason for Recall
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
Initiated
01-27-2026
Reported
02-11-2026
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SUN PHARMACEUTICAL INDUSTRIES INC
Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7

Batch or Lot Expiration Information

Lot# AD92721, Exp Date: 3/31/2027.